n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine has been researched along with pyrroles in 2 studies
| Studies (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Trials (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Recent Studies (post-2010) (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Studies (pyrroles) | Trials (pyrroles) | Recent Studies (post-2010) (pyrroles) |
|---|---|---|---|---|---|
| 214 | 5 | 58 | 26,129 | 2,815 | 12,100 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Warren, RB; Yiu, ZZ | 1 |
| Cooper, S; Hussain, A; Maddock, H; Mee, C; Sandhu, H | 1 |
1 review(s) available for n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and pyrroles
| Article | Year |
|---|---|
Novel Oral Therapies for Psoriasis and Psoriatic Arthritis.
Topics: Adamantane; Adenosine; Adenosine A3 Receptor Antagonists; Administration, Oral; Arthritis, Psoriatic; Azetidines; Biological Factors; Biological Therapy; Clinical Trials as Topic; Humans; Isonicotinic Acids; Janus Kinases; Niacinamide; Phosphodiesterase 4 Inhibitors; Piperidines; Protein Kinase Inhibitors; Psoriasis; Purines; Pyrazoles; Pyrimidines; Pyrroles; Receptors, Lysosphingolipid; rho-Associated Kinases; Sulfonamides; Thalidomide; Thiazoles | 2016 |
1 other study(ies) available for n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and pyrroles
| Article | Year |
|---|---|
Attenuation of Sunitinib-induced cardiotoxicity through the A3 adenosine receptor activation.
Topics: Adenosine; Adenosine A3 Receptor Agonists; Cell Survival; Heart; Heart Rate; Hemodynamics; HL-60 Cells; Humans; Indoles; MicroRNAs; Protein Kinase C-alpha; Pyrroles; Receptor, Adenosine A3; Signal Transduction; Sunitinib; Ventricular Function, Left | 2017 |